Document is current

Article History

Received: 11 May 2024

Revised: 11 May 2024

Accepted: 3 June 2024

First Online: 9 July 2024

Compliance with ethical standards

:

: The scientific guarantor of this publication is Wim H. van Zwam.

: The authors of this manuscript declare relationships with the following companies: Diana Aguiar de Sousa: Research grants (PI, collabotaror or consultant, pending and received grants) from Astrazeneca, Fundação Amélia de Mello, FCT: Nonfinancial support form Boehringer Ingelheim. Speakers Bureau/honoraria from Bayer, Bial, Astrazeneca. Consultant/advisory board: Daiichi-Sankyo, Astrazeneca, Organon. Wim van Zwam: Research grants (All paid to Institution) from Dutch Heart Foundation, Hersenstichting, ZonMW, Stryker, Medtronic, Cerenovus, Penumbra. Speaker fees (All paid to Institution) from Cerenovus, Stryker, NicoLab, Philips. Marc Ribo: consultant for: Anaconda Biomed (Co-founder), Medtronic, Cerenovus, Vesalio, Philips, Apta Targets, Nora Hrealth, Rapid Pulse, Perfuze, Methinks.

: No complex statistical methods were necessary for this paper.

: Written informed consent was not required.

: Institutional Review Board approval was not required

: Not applicable

: